CHEBI:75283 - miltefosine

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name miltefosine
ChEBI ID CHEBI:75283
Definition A phospholipid that is the hexadecyl monoester of phosphocholine.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information ChemicalBook:CB6370752, eMolecules:748094, Selleckchem:miltefosine-hexadecylphosphocholine
Download Molfile XML SDF
Wikipedia License
Miltefosine, sold under the trade name Impavido among others, is a medication mainly used to treat leishmaniasis and free-living amoeba infections such as Naegleria fowleri and Balamuthia mandrillaris. This includes the three forms of leishmaniasis: cutaneous, visceral and mucosal. It may be used with liposomal amphotericin B or paromomycin. It is taken by mouth. Common side effects include vomiting, abdominal pain, fever, headaches, and decreased kidney function. More severe side effects may include Stevens–Johnson syndrome or low blood platelets. Use during pregnancy appears to cause harm to the baby and use during breastfeeding is not recommended. How it works is not entirely clear. Miltefosine was first made in the early 1980s and studied as a treatment for cancer. A few years later it was found to be useful for leishmaniasis and was approved for this use in 2002 in India. It is on the World Health Organization's List of Essential Medicines.
Read full article at Wikipedia
Formula C21H46NO4P
Net Charge 0
Average Mass 407.56800
Monoisotopic Mass 407.31645
InChI InChI=1S/C21H46NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-25-27(23,24)26-21-19-22(2,3)4/h5-21H2,1-4H3
InChIKey PQLXHQMOHUQAKB-UHFFFAOYSA-N
SMILES CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
Roles Classification
Biological Role(s): anticoronaviral agent
Any antiviral agent which inhibits the activity of coronaviruses.
immunomodulator
Biologically active substance whose activity affects or plays a role in the functioning of the immune system.
apoptosis inducer
Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
protein kinase inhibitor
An EC 2.7.* (P-containing group transferase) inhibitor that interferes with the action of protein kinases.
antiprotozoal drug
Any antimicrobial drug which is used to treat or prevent protozoal infections.
antifungal agent
An antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.
Application(s): immunomodulator
Biologically active substance whose activity affects or plays a role in the functioning of the immune system.
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
antiprotozoal drug
Any antimicrobial drug which is used to treat or prevent protozoal infections.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing miltefosine (CHEBI:75283) has role anti-inflammatory agent (CHEBI:67079)
miltefosine (CHEBI:75283) has role anticoronaviral agent (CHEBI:149553)
miltefosine (CHEBI:75283) has role antifungal agent (CHEBI:35718)
miltefosine (CHEBI:75283) has role antineoplastic agent (CHEBI:35610)
miltefosine (CHEBI:75283) has role antiprotozoal drug (CHEBI:35820)
miltefosine (CHEBI:75283) has role apoptosis inducer (CHEBI:68495)
miltefosine (CHEBI:75283) has role immunomodulator (CHEBI:50846)
miltefosine (CHEBI:75283) has role protein kinase inhibitor (CHEBI:37699)
miltefosine (CHEBI:75283) is a phosphocholines (CHEBI:36700)
miltefosine (CHEBI:75283) is a phospholipid (CHEBI:16247)
INNs Sources
miltefosina ChemIDplus
miltefosine KEGG DRUG
miltéfosine WHO MedNet
miltefosinum ChemIDplus
Synonyms Sources
Hexadecylphosphocholine ChemIDplus
Hexadecylphosphorylcholine ChemIDplus
monohexadecylphosphocholine ChEBI
monohexadecylphosphorylcholine ChEBI
Manual Xrefs Databases
1810 DrugCentral
D02494 KEGG DRUG
Miltefosine Wikipedia
View more database links
Registry Numbers Types Sources
3690495 Reaxys Registry Number Reaxys
58066-85-6 CAS Registry Number ChemIDplus
58066-85-6 CAS Registry Number KEGG DRUG
Citations Waiting for Citations
Last Modified
23 April 2020